DJIA 17,081.89 -49.97 -0.29%
NASDAQ 4,796.61 -42.03 -0.87%
S&P 500 2,003.69 -13.77 -0.68%
market minute promo

NxStage Medical (NASDAQ: NXTM)

15.49 -0.54 (-3.37%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NXTM $15.49 -3.37%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $15.93
Previous Close $16.03
Daily Range $15.33 - $16.00
52-Week Range $12.79 - $19.63
Market Cap $982.8M
P/E Ratio -44.53
Dividend (Yield) $0.00 (0.0%)
Volume 291,641
Average Daily Volume 512,281
Current FY EPS -$0.31




Healthcare IT

NxStage Medical (NXTM) Description

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Website:

News & Commentary Rss Feed

NxStage Medical Keeps Growing, Sees Even Better Times Ahead

The dialysis-services company saw solid revenue growth and raised its guidance for the full 2015 year.

Nxstage Medical (NXTM): Strong Industry, Solid Earnings Estimate Revisions

Notable Two Hundred Day Moving Average Cross - NXTM

Insider Trading Alert - PPBI, DXPE And NXTM Traded By Insiders

NXTM January 2016 Options Begin Trading

Nxstage (NXTM) Shares March Higher, Can It Continue?

NxStage Medical's (NXTM) CEO Jeff Burbank on Q2 2015 Results - Earnings Call Transcript

Nxstage Medical Soars Following Better-Than-Expected Q2 Results

2:30pm ET: Nxstage Medical stock rises as much as 13% out of the gate following market-topping Q2 results, but has since settled into gains of around 7%.

NxStage Medical (NXTM) Q2 2015 Results - Earnings Call Webcast

Structurally Light On Growth, Baxter Has A Lot Of Work Ahead

See More NXTM News...

NXTM's Top Competitors

NXTM $15.49 (-3.37%)
Current stock: NXTM
$0.00 (0.00%)
Current stock:
MDT $72.79 (-0.30%)
Current stock: MDT
COV $0.00 (0.00%)
Current stock: COV